- US-listed companies
- BRAINSTORM CELL THERAPEUTICS INC.
- Income statement
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Income statement
Market cap
$11.03M
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Research & development | 24 | 26 | 29 | 5 | 5 | 2 | - | - | - | 22 | 15 | 14 | 11 | 5 | 4 |
| Operating expenses | 41 | 45 | 50 | 7 | - | - | - | - | - | - | - | - | - | - | - |
| Operating income | 44 | -3 | -5 | -9 | -9 | -5 | - | - | - | -32 | -25 | -25 | -21 | -12 | -10 |
| Provision for income taxes | -0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
| Net income | -4 | -3 | -5 | -9 | -8 | -5 | -5 | -14 | -23 | -32 | -24 | -24 | -17 | -12 | -10 |
| Earnings per share | - | - | - | - | - | - | - | - | - | - | -0.68 | -0.66 | -0.4 | -2.31 | -1.11 |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | -0.68 | -0.66 | -0.4 | -2.31 | -1.11 |